City page

Wroclaw biotech and pharma directory

This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.

Visible records7
Verified7
Strongest categoryDiagnostics
CITY OVERVIEWWroclaw, PolandWroclaw concentrates Polish antibody, aptamer, diagnostics, and d...
ProfileWroclawconcentratesPolish anti...
TrustSource review
StatusPublished record
Evidence
Visible records7
Verified7
Categories4
Regulated sites5
Avg sources / record0.0
City view

Where does this city read strongest?

Diagnostics (3), Therapeutics (2), and Drug discovery (1). Most visible records: Bioavlee S.A., Biotts S.A., and Genomtec S.A..

City view

Which standards and public evidence are already visible?

GMP (1), GLP (3), and ISO-13485 (2). Latest review: 24 April 2026. Review cycle: April 2026.

City view

Why does this city matter?

This page brings visible companies and infrastructure records into one practical view of Wroclaw.

By category

Wroclaw by category

Jump into a category page filtered to this country only.

Full list

Wroclaw biotech and pharma directory

7 city records currently match the active filter.

Current review cycle

Bioavlee S.A.

WroclawPolandDiagnostics

Wroclaw diagnostic robotics company developing AI-powered rapid bacterial identification through image-analysis microbiology for point-of-care infectious-disease diagnosis.

Lead
Michal K. WroneckiChief Executive Officer
Scale
Medical-device and AI diagnostics delivery
0 sources38d reviewMicrobiology diagnostics medical deviceWroclaw commercial registry listing
Current review cycle

Biotts S.A.

WroclawPolandTherapeutics

Wroclaw drug-delivery biotech with the MTC-Y Multifunctional Transdermal Carrier platform for transdermal insulin, oncology, and diabetes formulations, partnered with BIOTON.

Lead
Jan Henk HendriksChief Executive Officer
Scale
Transdermal drug-delivery R&D
0 sources38d reviewWroclaw Technology Park tenancyBIOTON pharmaceutical partnership
Current review cycle

Genomtec S.A.

WroclawPolandDiagnostics

Wroclaw point-of-care molecular diagnostics developer with isothermal nucleic acid amplification technology (SNAAT) for cartridge-based respiratory and infectious-disease panels, listed on Warsaw Stock Exchange.

Lead
Miron TokarskiChief Executive Officer and Co-Founder
Scale
POC diagnostic device development
0 sources38d reviewWarsaw Stock Exchange listing (GMT)CE-IVD device pipeline
Current review cycle

Hemolens Diagnostics Sp. z o.o.

WroclawPolandDiagnostics

Wroclaw medical-device software company building Cardiolens FFR-CT Pro for non-invasive cardiology diagnostics through coronary CT and blood-pressure fusion with blood-flow simulation.

Lead
Wojciech JezewskiChief Executive Officer
Scale
Medical-device software delivery
0 sources38d reviewCE-marked medical device (implied by EU clinical deployment)ISO 13485 likely for MDR compliance
Current review cycle

Pure Biologics S.A.

WroclawPolandBiotech

Wroclaw antibody and aptamer discovery biotech with PureApta platform, extracorporeal apheresis therapies, and more than thirty specialist laboratories across 1,400 square meters of lab space.

Lead
Filip JelenChief Executive Officer and Co-Founder
Scale
ISO 17025 plus GMP-capable medium-scale production
0 sources38d reviewPN-EN ISO 17025GLP and GMP-capable medium-scale productionWarsaw Stock Exchange listing (NewConnect and main market)
Current review cycle

Bioceltix

WroclawPolandTherapeutics

Wroclaw veterinary biologics company developing allogeneic cell therapies and regulated animal-health products.

Lead
Łukasz BzdzionPresident of the Management Board
Scale
Veterinary biologics platform
0 sources78d reviewBiological-drug development quality systemsVeterinary therapeutics governance
Current review cycle

Captor Therapeutics

WroclawPolandDrug discovery

Wroclaw targeted-protein-degradation company building oncology and immunology programmes around molecular glues and degrader chemistry.

Lead
Michał WalczakChief Executive Officer and Chief Scientific Officer
Scale
Precision-degradation discovery platform
0 sources78d reviewDrug-discovery quality systemsClinical-transition programme governance
Related briefs

Briefs that mention Wroclaw

Market brief

Polish Biotech & Pharma Landscape 2026: Warsaw, Wroclaw, Krakow

A practical map of the Polish biotech and pharma landscape in 2026 — Warsaw as pharma and regulatory anchor, Wroclaw as innovation belt, Krakow as discovery cluster, plus CDMO, clinical-research, and supply-chain layers — with 39 operators in the directory.

Open brief
Market brief

Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus

Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.

Open brief
Market brief

Cell & Gene Therapy Europe 2026: CAR-T, Stem Cell, ATMP, Regenerative

A practical map of the European cell and gene therapy landscape in 2026 — CAR-T and TCR-T therapeutics, stem-cell and regenerative ATMPs, tissue engineering, plus the viral-vector CDMO and tools supply chain — across 26 operators in the directory.

Open brief
Next step

Read the city, then widen the view.

Use country and regional pages for wider context, and the company suggestion form for new candidate records.